Investor Stock List
Ranked #1,876 of 8,699 institutional investors

Logos Global Management LP

San Francisco, CA

$1.45B
US stock portfolio at live prices · today +$2.2M (+0.15%)
Market closed. Prices as of Nov 20, 7:41 AM ET
Value at quarter end (Q3 2026)
$1.65B
Change from Q2 2026
−$668.2M (−28.77%)
Positions
49 · 12 new, 22 sold out
Filed
Nov 16, 2026

Not counted in the ranking: call options on $202M of stock. $60.4M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
PRAX 9.09%RVMD 6.58%ERAS 5.77%CGON 5.49%IRON 5.32%
StockSharesValue, live% of portfoliovs Q2 2026
PRAX Praxis Precision Medicines, Inc.425,000$132M9.09%Added +63%
RVMD Revolution Medicines, Inc.600,000$95.7M6.58%Reduced −14%
ERAS Erasca, Inc.5,900,000$83.9M5.77%Reduced −51%
CGON CG Oncology, Inc.975,000$79.9M5.49%Reduced −3%
IRON Disc Medicine, Inc.1,015,000$77.3M5.32%Added +16%
IDYA IDEAYA Biosciences, Inc.2,850,000$74.6M5.13%Reduced −5%
ABVX ABIVAX Société Anonyme870,000$70.2M4.83%Reduced −15%
BNTX BioNTech SE650,000$52.9M3.64%Reduced −36%
ELVN Enliven Therapeutics, Inc.1,080,000$50.1M3.45%Added +132%
TNGX Tango Therapeutics, Inc.2,150,000$48.8M3.36%Reduced −25%
DYN Dyne Therapeutics, Inc.3,000,000$48.1M3.31%Added +18%
DNTH Dianthus Therapeutics, Inc.500,000$42.4M2.92%Reduced −38%
MDGL Madrigal Pharmaceuticals, Inc.100,000$39.7M2.73%New
NBIX Neurocrine Biosciences, Inc.250,000$39.1M2.69%New
OCUL Ocular Therapeutix, Inc.6,000,000$35.2M2.42%Added +13%
COGT Cogent Biosciences, Inc.1,250,000$34.7M2.39%Added +39%
MAZE Maze Therapeutics, Inc.935,000$30.3M2.09%Reduced −52%
BLTE Belite Bio, Inc200,000$30.2M2.08%Reduced −20%
AXSM Axsome Therapeutics, Inc.175,000$23.7M1.63%New
OLMA Olema Oncology, Inc.3,208,875$22.9M1.58%Unchanged
MANE Veradermics Inc170,000$21.1M1.46%Reduced −6%
PBLS Parabilis Medicines, Inc.750,000$20.7M1.43%Added +43%
TRVI Trevi Therapeutics, Inc.1,445,000$19.8M1.36%Reduced −23%
APMD Apnimed, Inc.1,100,000$19.0M1.31%New
QUIT Achieve Life Sciences, Inc.3,200,000$18.8M1.29%Reduced −41%
GPCR Structure Therapeutics Inc.1,000,000$17.1M1.18%Added +100%
MLTX MoonLake Immunotherapeutics1,500,000$16.5M1.14%Reduced −44%
VERA Vera Therapeutics, Inc.600,000$16.1M1.10%Reduced −73%
AVBP ArriVent BioPharma, Inc.1,350,000$15.2M1.05%Added +35%
YARW Yarrow Bioscience, Inc.1,026,258$14.6M1.00%New
SRPT Sarepta Therapeutics, Inc.1,000,000$14.2M0.98%New
IMCR Immunocore Holdings plc500,000$13.3M0.92%Reduced −17%
DFTX Definium Therapeutics, Inc.350,000$10.3M0.71%Added +338%
LBRX LB Pharmaceuticals Inc250,000$10.0M0.69%Reduced −57%
DSGN Design Therapeutics, Inc.1,000,000$9.3M0.64%Reduced −67%
ETRA Electra Therapeutics, Inc.1,000,000$8.9M0.62%New
NERV Minerva Neurosciences, Inc.3,288,777$7.0M0.48%Unchanged
VKTX Viking Therapeutics, Inc.200,000$5.2M0.36%New
IRD Opus Genetics, Inc.1,000,000$4.1M0.28%New
EDIT Editas Medicine, Inc.2,222,000$3.8M0.26%Unchanged
JBIO Jade Biosciences, Inc.200,000$3.0M0.21%Reduced −82%
IMVT Immunovant, Inc.85,000$2.8M0.19%Reduced −87%
OKUR OnKure Therapeutics, Inc.963,855$2.7M0.18%Unchanged
VOGX Vogenx, Inc.205,000$2.6M0.18%New
UNCY Unicycive Therapeutics, Inc.473,563$1.7M0.12%Unchanged
TNXP Tonix Pharmaceuticals Holding Corp.550,000$1.4M<0.1%New
SEPN Septerna, Inc.23,548$923K<0.1%Unchanged
PTN Palatin Technologies, Inc.129,260$637K<0.1%Reduced −1%
LGVN Longeveron Inc.192,308$350K<0.1%New

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
CLDX Celldex Therapeutics, Inc.2,100,000$58.7M
REPL Replimune Group, Inc.2,500,000$48.1M
CMPS COMPASS Pathways plc2,250,000$19.5M
XENE Xenon Pharmaceuticals Inc.450,000$16.9M
MLYS Mineralys Therapeutics, Inc.1,050,000$14.9M
RYTM Rhythm Pharmaceuticals, Inc.125,000$14.6M
SMMT Summit Therapeutics Inc.1,350,000$14.3M
VOR Vor Biopharma Inc.650,000$12.0M
RCUS Arcus Biosciences, Inc.650,000$10.3M
SRRK Scholar Rock Holding Corporation200,000$10.1M
ODTX Odyssey Therapeutics, Inc.521,736$9.6M
AMLX Amylyx Pharmaceuticals, Inc.350,000$9.2M
DBVT DBV Technologies S.A.915,000$8.6M
AVTX Avalo Therapeutics, Inc.1,150,000$7.8M
IMMX Immix Biopharma, Inc.1,000,000$7.0M
QTTB Q32 Bio Inc.800,000$6.8M
FTH Faeth Therapeutics, Inc.722,020$6.3M
RLAY Relay Therapeutics, Inc.350,000$5.6M
ANNX Annexon, Inc.1,500,000$5.1M
ACAD Acadia Pharmaceuticals Inc.250,000$4.4M
ACRS Aclaris Therapeutics, Inc.200,000$700K
TENX Tenax Therapeutics, Inc.300,000$417K